Better Together: Exploring the Synergy of Germline and Somatic Testing for Treating and Managing Cancer

This session explores how somatic and germline genetic testing in oncology can enable more comprehensive insights into cancer biology and treatment. Traditionally, these two testing modalities have been performed independently, limiting the scope of data that can inform clinical decisions. We aim to demonstrate the clinical utility of integrating somatic and germline data to guide therapeutic decisions, particularly for cancers where germline and somatic variants influence treatment.

Speakers: 

Rebecca Previs, MD, MS
Medical Affairs Director, Oncology, Labcorp  

Sarah Young (Nielsen), MS, CGC
Clinical Program Manager, Oncology, Labcorp